Contact this trialFirst, we need to learn more about you.
Immunotherapy
Immune + Targeted Therapies for Renal Cell Carcinoma
Recruiting1 awardPhase 1 & 2
Durham, North Carolina
This trial is a substudy of a larger study that is testing experimental treatments for renal cell carcinoma. The goal of this substudy is to see if the combination of investigational agents is safe and effective in people with advanced ccRCC.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.